Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 17, Pages 6829-6834
Publisher
Proceedings of the National Academy of Sciences
Online
2013-04-09
DOI
10.1073/pnas.1217002110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
- (2012) Hervé Sartelet et al. HISTOPATHOLOGY
- Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cells
- (2010) Y. K. Wang et al. CARCINOGENESIS
- Lipid rafts play an important role for maintenance of embryonic stem cell self-renewal
- (2010) Min Young Lee et al. JOURNAL OF LIPID RESEARCH
- The Stem Cell Marker CD133 (Prominin-1) is Phosphorylated on Cytoplasmic Tyrosine-828 and Tyrosine-852 by Src and Fyn Tyrosine Kinases
- (2009) Dominique Boivin et al. BIOCHEMISTRY
- Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
- (2009) Bijay S. Jaiswal et al. CANCER CELL
- Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients
- (2009) K. V. Lu et al. CANCER RESEARCH
- Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
- (2009) H. T. Yuan et al. MOLECULAR AND CELLULAR BIOLOGY
- PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo
- (2008) D. Hambardzumyan et al. GENES & DEVELOPMENT
- The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells
- (2008) Scott Bidlingmaier et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- CD133 identifies perivascular niches in grade II–IV astrocytomas
- (2008) Karina Christensen et al. JOURNAL OF NEURO-ONCOLOGY
- Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
- (2008) Kyeung Min Joo et al. LABORATORY INVESTIGATION
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
- (2008) Jinyan Du et al. NATURE BIOTECHNOLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
- Glioma Formation, Cancer Stem Cells, and Akt Signaling
- (2008) Dolores Hambardzumyan et al. Stem Cell Reviews and Reports
- Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition
- (2008) Christine E. Eyler et al. STEM CELLS
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
- (2007) Jian Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells
- (2007) P. B Dirks PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started